Breakthrough Device Route, Registries On Wish List At Senate Hearing
This article was originally published in The Gray Sheet
Executive Summary
Industry stakeholders listed their priorities to improve the medical regulatory process and research during a second hearing at the Senate Health, Education, Labor and Pensions Committee which is working on its own version of the House's 21st Century Cures bill.